Evidence map›Paper›PMID 40410769›Full record

ArticleWorld journal of surgical oncology2025

A Rare Case of Adrenal Intravascular Large B-Cell Lymphoma Diagnosed via Percutaneous Needle Biopsy.

Jiafei Zeng, Jin Li, Shuai Luo, Jinjing Wang

Abstract readCase Reports
In one paragraph

Article in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jiafei ZengDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi City, Guizhou Province, People's Republic of China.
Jin LiDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi City, Guizhou Province, People's Republic of China.
Shuai LuoDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi City, Guizhou Province, People's Republic of China.
Jinjing WangDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi City, Guizhou Province, People's Republic of China. jinjingwangls@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntravascular large B-cell lymphoma (IVLBCL) is a rare subtype of diffuse large B-cell lymphoma, predominantly affecting the elderly. The disease often involves multiple tissues and organs, leading to a wide range of nonspecific symptoms. Early detection is challenging due to the absence of prominent signs such as enlarged lymph nodes or significant blood and bone marrow abnormalities in the early stages. Moreover, biopsy specimens may be insufficient for accurate diagnosis, resulting in a high false-negative rate and delayed treatment initiation. CASE PRESENTATION: A 61-year-old male presented with a bilateral adrenal mass detected during routine examination. The patient had a history of diabetes, managed with regular antidiabetic medications and good blood sugar control for over a year. Symptoms included dizziness and mild bilateral flank discomfort. Imaging revealed patchy, soft tissue lesions in both adrenal glands on an upper abdominal CT scan. The larger lesion measured 71 × 37 mm on the left, and 51 × 31 mm on the right. Enhanced imaging showed mild to moderate enhancement, with neoplastic lesions or metastasis suspected. A CT-guided percutaneous biopsy was performed. Histopathological examination revealed large or medium-sized lymphoma-like cells localized to endothelial markers CD31 and CD34-positive lumen epithelium, with strong diffuse positivity for B-lymphocyte markers. The final diagnosis was IVLBCL. The patient was treated with rituximab combined with CHOP chemotherapy and discharged without significant symptoms.

conclusionsIVLBCL is often overlooked due to its varied and nonspecific clinical presentation, making early diagnosis difficult. The disease progresses rapidly and has a poor prognosis, with definitive diagnosis relying on pathological findings. Increased awareness of this rare lymphoma is crucial, particularly for diagnosing needle biopsy specimens in patients with mild symptoms and no distinct space-occupying lesions. Careful morphological examination, supported by targeted immunohistochemical staining (for B-cell and endothelial markers), is essential for timely diagnosis.

Indexed as

Adrenal Gland NeoplasmsLymphoma, Large B-Cell, DiffuseVascular NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsBiopsy, NeedleCyclophosphamideDoxorubicinHumansMaleMiddle AgedPrednisonePrognosisRituximabTomography, X-Ray ComputedVincristineCyclophosphamideDoxorubicinPrednisoneRituximabVincristineAdrenal glandDifferential diagnosisIntravascular large B-cell lymphomaNeedle biopsyPathological diagnosis

Identifiers

PMID40410769
PMCPMC12100946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.